Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection

NCT04526912 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Study met predefined futility criteria for efficacy endpoints.

Conditions

Acute Lung Injury

Interventions

DRUG: VIB7734
DRUG: Placebo

Sponsor

Viela Bio